Arterially directed therapies for hepatocellular carcinoma. Review uri icon

Overview

abstract

  • OBJECTIVE: Arterially directed therapies for hepatocellular carcinoma are used for patients who are not candidates for surgery or ablation and for those who need a bridge or down-staging to liver transplantation. These therapies seem to prolong the overall survival when compared with supportive care. CONCLUSION: Chemoembolization, particle embolization, drug-eluting beads, and radioembolization have been used for locoregional control. This review discusses patient selection, techniques, safety, clinical outcomes, and imaging findings related to these therapies.

publication date

  • October 1, 2011

Research

keywords

  • Carcinoma, Hepatocellular
  • Embolization, Therapeutic
  • Liver Neoplasms
  • Neoplasm Staging

Identity

Scopus Document Identifier

  • 80053263681

Digital Object Identifier (DOI)

  • 10.2214/AJR.11.7554

PubMed ID

  • 21940531

Additional Document Info

volume

  • 197

issue

  • 4